News

Why Is NewAmsterdam Pharma Stock Trading Higher On Tuesday?

On Tuesday, NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) revealed topline data from its Phase 3 BROADWAY clinical trial evaluating obicetrapib in adult patients with atherosclerotic cardiovascular disease (ASCVD) and/or heterozygous familial hypercholesterolemia (HeFH), whose LDL-C is not adequately controlled, despite being on maximally tolerated lipid-lowering therapy. ASCVD is a chronic disease that occurs when plaque builds up in the walls of arteries, narrowing them and reducing blood flo

Muni Managers Launch Record ETFs to Build on $142 Billion Market

(Bloomberg) -- Wall Street’s biggest money managers are zeroing in on a $142 billion segment of the municipal-bond market.Most Read from BloombergBrace for a Nationwide Shuffle of Corporate HeadquartersCloud Computing Tax Threatens Chicago’s Silicon Valley DreamA Chicago Skyscraper Cements the Legacy of a Visionary Postmodern ArchitectSan Francisco, Paris Named Best Cities for Urban TransportationDC Business Leaders Welcome Return-to-Office Policy Under TrumpThere have been 27 muni exchange-trad

Gold Adds to Advance Before US Data That May Shape Fed Rate Move

(Bloomberg) -- Gold rose for a third day as traders shifted their focus to key US inflation reports due this week that may shape expectations ahead of the Federal Reserve’s final interest-rate decision of the year. Most Read from BloombergBrace for a Nationwide Shuffle of Corporate HeadquartersCloud Computing Tax Threatens Chicago’s Silicon Valley DreamA Chicago Skyscraper Cements the Legacy of a Visionary Postmodern ArchitectSan Francisco, Paris Named Best Cities for Urban TransportationDC Busi

Argentina monthly inflation seen under 3% in November, but sticky

Argentina's monthly inflation is likely to have remained under 3% in November, near its lowest level of the year but slightly up from the month before, underscoring the challenge for libertarian president Javier Milei to rein in prices. A Reuters poll of analysts published on Tuesday showed a median forecast rise of 2.8% in the month after 2.7% in October. Argentina has been battling to bring down what has been the highest inflation rate in the world, peaking at almost 300% a year.